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THE human parathyroid hormone N-terminal fragment
[hPTH-(1-34)] increases the conversion of exogenous
unsaturated fatty acids to prostaglandins (PGs) in calvarial
homogenates. Enzyme activities were completely blocked
by indomethacin (5 10
-7 M), a PG synthase inhibitor,
and actinomycin D (5 #M), an inhibitor of transcription,
by binding to DNA. In addition, a potent inhibitor of
protein synthesis, cycloheximide (10/M), totally inhibited
the stimulating effect of hPTH-(1-34) on prostaglandin
endoperoxide synthase (PG synthase, EC 1.14.99.1). The
stimulatory effect ofhPTH-(1-34) on PG synthase was also
reduced by the addition of stannous chloride. However,
epidermal growth factor (EGF), platelet-derived activating
factor (PDGF), and ionophore A23187 did not show the
same stimulating effect as hPTH-(1-34) on PG synthase
in calvaria. The results further demonstrated that PG
synthase is a membrane-bound enzyme in chick calvaria.
In this communication, evidence is presented that
hPTH-(1-34) stimulates the de novo synthesis of PG
synthase as demonstrated by the increased activity in
calvarial homogenates and microsomes.
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Introduction
Parathyroid hormone (PTH) is a single chain
84-amino acid peptide (molecular weight of 9 500)
secreted by the parathyroid glands. However, the
structural requirements necessary for full biological
activity are virtually satisfied by the NHe-terminal
34-amino acid fragment. Bone and kidney are the
two principal target organs affected by PTH. PTH
stimulates the breakdown of phospholipids from
the rat tibia which occurs at the same time as
calcium mobilization
2 and stimulates phosphoinosi-
tide turnover in mouse osteoblasts. In contrast,
several reports have demonstrated that PTH
stimulates the growth of bone4’5 and cartila-
ge. 6’7 Endogenous skeletal prostaglandin (PG) pro-
duction may participate in bone resorption and
bone formation. PGs may not mediate the action
of PTH on bone resorption. However, PGs do
show a very close relationship with the action of
PTH on skeletal tissues.
1-13 It has been demon-
strated that the human parathyroid hormone
N-terminal fragment [hPTH-(1-34)] stimulates
PGE2 synthesis by chick calvaria in an organ
culture. It appears that hPTH-(1-34) stimulates the
bone cells to convert arachidonic acid to prostaglan-
din E2 (PGE2), but does not activate the release of
stored arachidonic acid.
13
Prostaglandin biosynthesis involves the initial
conversion of arachidonic acid to cyclic endoper-
oxide intermediates designated PGG2 and PGH2 by
prostaglandin endoperoxide synthase.
14 These rela-
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tively unstable compounds are then metabolized by
other enzymes to form stable PGs, or are
transformed into non-prostaglandin derivatives, is
The mechanism by which hPTH-(1-34) increases
the synthesis of PGE2 in chick calvaria appears to
be related to the activation of enzyme activity in
the biosynthesis of prostaglandins.
3 It is important
to investigate whether hPTH-(1-34) can stimulate
the de novo synthesis of PG synthase in chick
calvaria. In this report, it was found that
hPTH-(1-34) increases the conversion of exoge-
nous unsaturated fatty acids to PGs in calvarial
homogenates and microsomes.
PG synthase is a membrane-bound enzyme which
has been purified from sheep,6’7 rat adipose
tissue,
18 rabbit renal papilla,
9 bovine seminal
vesicles,
2 and Swiss mouse 3T3 fibroblasts.
2 The
enzyme possesses two enzymatic activities, a
cyclooxygenase which catalyses the oxygenation of
polyunsaturated substrates such as arachidonic acid
to form PGG2 and a peroxidase which can use a
variety of electron donors to reduce PGG2 to
PGH2. This report is the first study which
demonstrated that PG synthase is a membrane-
bound enzyme in skeletal tissue.
Materials and Methods
Materials" Preincubated fertilized chick eggs were
obtained from Miaoli Livestock Propagation
Station, Taiwan Livestock Research Institute.
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Synthetic human parathyroid hormone N-terminal
1-34 peptide [hPTH-(1-34), 3000 IU/mg] was
purchased from Bachem Inc. (Torrence, CA, USA).
This material was dissolved in a solution containing
0.5% sodium chloride, 0.2% sodium acetate, and 1%
bovine serum albumin, aliquoted and stored frozen
at -70C until use. Epidermal growth factor
(EGF) and platelet derived growth factor (PDGF)
were obtained from Collaborative Research Inc.
(Two Oak Park, Bedford, MA, USA).
Labelled compounds, 3H-arachidonic acid (202
Ci/mmol), 3H-PGE2 (184 Ci/mmol), H-PGF2 (180
Ci/mmol), H-6-keto-PGFl (157 Ci/mmol),
H-PGD2 (192Ci/mmol) and H-TXB2 (180
Ci/mmol) were purchased from Amersham Cor-
poration (Arlington Heights, IL, USA). Linear-K
preadsorbent thin-layer chromatography plates
were purchased from Whatman International Ltd.
(Maidstone, England). A BioRad protein assay was
obtained from BioRad Laboratories (Richmond,
CA, USA). Octadecylsilyl (ODS)-silica columns
(Sep-Pak C18 cartridges) were obtained from
Waters Associates (Milford, MA, USA).
Trypsin and a penicillin-streptomycin solution
were purchased from Gibco Lab. (Grand Island,
NY, USA). Foetal calf serum (FCS) was purchased
from Biofluids Inc. (Rockville, MD, USA).
Fungizone was purchased from E. R. Squibb &
Sons Inc. (Princeton, NJ, USA). Dithiothreitol,
hydroquinone, methanol, ethanol, isooctane, and
acetic acid were purchased from Merck (Darmstadt,
Germany). Ethyl acetate was obtained from
Mallinckrodt Inc. (Paris, KY, USA). BGJb medium
(Fitton-Jackson Modification), arachidonic acid, in-
domethacin, glutathione, cycloheximide, actinomy-
cin D, stannous chloride, ionophore, haemin,
sodium dihydrogen phosphate, sodium phosphate,
Trizma hydrochloride, EDTA, sodium chloride,
magnesium chloride, sodium bicarbonate, po-
tassium phosphate, calcium chloride, and ascorbic
acid were obtained from Sigma Corporation (St
Louis, MO, USA).
Methods: Preparation of calvarial homogenates Calvariae
were dissected aseptically from. 17-day-old chick
embryos and cultivated as previously described by
Yang et al.
22 Routinely, the paired bones were
preincubated in an organ culture system for 24 h,
then the medium was replaced with fresh medium
containing different tested additions for appropriate
time periods. The paired bones from 20 chicks were
randomly assigned to the experimental groups.
After this preincubation, paired bones from each
group were harvested, weighed, and resuspended
in 4ml of sodium phosphate buffer (10mM
NaH2PO4, 10 mM Na2HPO4, 100/M dithio-
threitol, pH 7.4) and then homogenized with a
Polytron operated at full speed for 2 min. The
homogenates were centrifuged at 400 g for 5 min
at 4C to remove large unminced fragments. The
supernatant was removed and incubated with
10/M cold arachidonic acid (AA) and 10 Ci
3H-arachidonic acid in an equal volume of 0.2 M
Tris-chloride buffer (pH 8.5) containing 2mM
glutathione, 1 mM hydroquinone, and 2 #M
haemin at 37C for 10min. The reaction was
terminated by the addition of 2 vol. of ethanol and
was ready for extraction and purification of
eicosanoids.
Isolation of microsomesfrom calvaria The procedures for
isolating microsomes from calvariae were a
modification of those of Stern and Vance.2 All
procedures were performed at 4C unless otherwise
indicated. After a preincubation period of 36 h with
or without hPTH-(1-34), the calvariae were
harvested and resuspended in an appropriate
volume of sodium phosphate buffer (10mM
NaH2PO4, 10 mM Na2HPO4, 100 #M dithio-
threitol, pH 7.4) and then homogenized with a
Polytron operated at full speed for 2min.
Homogenates were centrifuged at 12 000 g for
15 min. The resulting supernatants were harvested
and centrifuged at 100000 g for 1 h to
obtain cytosol and microsomal pellets. The
supernatant was removed and the pellet was
homogenized in fresh sodium phosphate buffer
equivalent to one-half the volume of the total
reaction mixture. The microsomes were further
incubated with 10 #M cold arachidonic acid and
2/,Ci (9.4 nM) H-arachidonic acid in an equal
volume of 0.2 M Tris-chloride buffer (pH 8.5)
containing 2 mM glutathione, 1 mM hydroquinone,
and 2/M haemin at 37C for 10 min. The reaction
was terminated by the addition of 2 vol. of
ethanol and was ready for extraction and separation
of eicosanoids.
Extraction and purification of eicosanoids: The incubation
precipitates from calvarial homogenates and micro-
somes were centrifuged at 800 g" for 10 min at
4C, and the supernatant layer was evaporated to
aqueous phase. Ethanol was added to the residues
to achieve a final concentration of 15% ethanol. The
biological sample was further acidified to pH 3.5
with 1 M citric acid and applied to an ODS-silica
column (Sep-Pak C18 cartridge). The Sep-Pak
cartridge was attached to a 20 ml polypropylene
Luerlok syringe and washed with 20 ml of ethanol
and water successively. The column was washed
with 20 ml of water, 20 ml 15% aqueous ethanol,
and 20 ml of petroleum ether sequentially. The
eicosanoids were eluted with 10ml of ethyl
acetate.24 The collected samples were dried by
evaporation under a stream of nitrogen. The
residues were then reconstituted in 1 ml of ethanol
and filtered through a 0.45 #m filter (Millipore).
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The samples were again dried by evaporation under
a stream of nitrogen, reconstituted in 50 #1 of
chloroform/methanol (2"1, v/v) and prepared for
thin-layer chromatography.
Thin-layer chromatography: Thin-layer chromatography
was performed by a method described previous-
ly.
13 After TLC, the radioactivity of the spots was
determined by directly counting the scraped spots
using liquid scintillation spectroscopy. The activity
of prostaglandin endoperoxide synthase was de-
termined by measuring the conversion of exoge-
nous arachidonic acid to PGE2.
Results
Previous experiments have shown that a 36-h
preincubation with hPTH-(1..-34) can activate
endogenous PGE2 synthesis and mineral mobiliza-
tion in intact chick calvaria. 13’2s In this report, it
was further found that human PTH-(1-34) at a
concentration of 0.6/g/ml stimulates PG synthase
activity (about a three-fold increase) in chick
calvaria. EGF at a concentration of 20 ng/ml and
PDGF at a concentration of 20 mU/ml had no
stimulatory effect on PG synthase activity (Fig. I(A)
and Table 1). Ionophore A23187 at a concentration
of 10 #M also had no eect on this enzyme activity
(Fig. I(B) and Table 1).
The stimulatory effect of hPTH-(1-34) on PG
synthase in chick calvaria, as well as the basal
activity of PG synthase, was blocked by a
cyclooxygenase inhibitor, indomethacin (5 10 -7
M), and a transcription blocker, actinomycin D
(5/M). Moreover, the stimulatory effect of
hPTH-(1-34) was completely abolished by a
translation inhibitor, cycloheximide (10/M) (Fig.
I(B) and Table 1), as it brought the activity of PG
synthase back to the basal level. It appears that
hPTH-(1-34) stimulates the de novo synthesis of PG
synthase in calvaria.
Stannous chloride was also included in the
experiments to reduce untransformed endoperoxide
to prostaglandin F2 (PGF2).
4 The stimulatory
effect of hPTH-(1-34) on PG synthase was blocked
(statistically significant) by the addition of stannous
chloride (1.9 mg/ml, 10/,zM) in ethanol; however,
the total enzyme activity level was still higher than
the basal levels (Table 1).
We then tried to identify the location of PG
synthase in chick calvaria. Human PTH-(1-34)
stimulates the de novo synthesis of PG synthase in
the microsomal fraction of the calvariae but not in
FIG. 1. (A) Autoradiograph of a TLC plate demonstrates the effect of hPTH-(1-34) and other additives on the conversion oT arachidonic
acid (AA) to prostanoids by chick calvarial homogenates. Lane prostanoid standards. Lane 2: hPTH-(1-34) (0.6 #g/ml 1.4 x 10 M). Lane 3: EGF
(20/g/ml). Lane 4: PDGF (20mU/ml). Lane 5: control. (B) Autoradiograph of a TLC plate demonstrates that the effect of blocking
agents and effectors on PTH-induced synthesis of prostanoids by chick calvarial homogenates. Lane hPTH-(1-34) (0.6 #g/ml) + cycloheximide (10 #M).
Lane 2: hPTH-(1-34) (0.6#g/ml)+actinomycin (5#M). Lane 3: hPTH-(1-34) (0.6#g/ml)+indomethacin (5 x 10-rM). Lane 4: hPTH-(1-34)
(0.6#g/ml) + stannous chloride (1.9 mg/ml). Lane 5: ionophore A23187 (10#M). (C) Autoradiograph of a TLC plate demonstrates
that PG synthase activity stimulated by hPTH-(1-34) can only be recovered in the microsomal fraction of chick calvaria. Lane 1: hPTH-(1-34) (0.6 #g/ml),
microsomal fraction. Lane 2: control, microsomal fraction. Lane 3: hPTH-(1-34) (0.6 #g/ml), cytosol fraction. Lane 4: control, cytosol fraction. Lane 5:
prostanoid standards.
Mediators of Inflammation. Vol 2.1993 145C-Y. Yang et al.
Table 1. The effect of hPTH-(1-34) and other additives on PG
synthase activities in chick calvariae
Additions
PG synthase activity,
pg of PGE2 synthesized per





hPTH + cycloheximide (10/M)
hPTH + actinomycin D (5/M)
hPTH + INDO (5 x 10-7 M)











The calvariae were incubated with different additions for 36 h,
with the exception of the indomethacin (INDO) group which was
incubated overnight. Indomethacin was preincubated for h
before adding hPTH-(1-34) in the hPTH + INDO group. After this
preincubation, the bones were harvested and homogenized with
a Polytron and centrifuged at 400 x g for 10 min at 4C. The
supernatant was harvested and incubated with 10/M cold
arachidonic acid and 10/Ci aH-arachidonic acid for 10 min at
37C. The prostanoids were then extracted with a Sep-Pak C18
cartridge and separated by TLC, and the enzyme activity was
determined as described (for details of these procedures refer
to Materials and Methods). Data are represented as the
mean +_ S.E. (disintegrations per min) for triplicate incubations
of bone homogenates prepared from 20 chick calvariae.
*Significantly different from control, as determined by Student’s
non-paired /-test (p < 0.05)" Significantly different from hPTH
treatment alone, as determined by Student’s non-paired /-test
(p < 0.05).
the cytosol fraction (Fig. 1(C)). These findings
further suggest that PG synthase in chick calvaria
in a membrane-bound protein.
Discussion
The action of PTH on bone metabolism may
involve several ’second messengers’, including
cAMP,
26 calcium,
2v the Na+-Ca2+ exchange mech-
anism
28 and prostaglandins.
29 In previous publica-
tions, it was demonstrated that hPTH-(1-34)
stimulates calcium mobilization
25 and PGE2 synth-
esis
13 in chick calvaria. In this communication, it
has been further found that hPTH-(1-34) stimulates
the de novo synthesis of PG synthase in chick
calvaria. The authors speculate that PG synthase
may be involved in the action of hPTH-(1-34) on
bone resorption or bone formation which are
coupling factors controlling bone metabolism.
Since PGE2 was the predominant eicosanoid
produced by chick calvaria, the activity of PG
synthase was determined by measuring the
conversion of exogenous arachidonic acid to PGE2.
PGF2 was the second major prostanoid to appear
on TLC. Trace amounts of PGB2, PGD2, an
unknown product that eluted before 6-keto-PGFl
(more polar than 6-keto-PGFl), an unknown
product that eluted after PGE2 (less polar than
PGE2), and an unknown product eluted after PGD2
(less polar than PGD2) were also detected.
Epidermal growth factor is a 53-amino acid
polypeptide isolated from male mouse submaxillary
glands, which stimulates PGE2 synthesis in mouse
calvaria.3’31 Tashjian et al.2 found that a low
concentration of PDGF stimulates bone resorption
via the enhanced local production of PGE2. In
previous observations, it was found that the use of
different concentrations of EGF, PDGF, bradyki-
nin and ionophore do not stimulate PGE2 synthesis
in chick calvaria. It was also noted that ionophore
at a concentration of 10/.tM has no deleterious
effects on chick calvaria (unpublished data). Lack
of responsiveness to these agonists may be due to
a difference in species. In this study, the results
further demonstrated that EGF, PDGF and
ionophore have no stimulatory effects on the de novo
synthesis of PG synthase in chick calvaria. On the
other hand, it was found that hPTH-(1-34) does
not have a stimulatory effect on PG synthesis in rat
calvaria, whereas hPTH-(1-34) does show a minor
effect (not statistically significant) in mouse calvaria
(unpublished data). These observations all support
the highly specific action of hPTH-(1-34) on chick
calvaria.
The temporal sequence of PG synthase synthe-
sized by human dermal fibroblasts can be separated
into an early transcriptional stage and a subsequent
translational stage.
33 The results in Table 1 indicate
that the DNA transcription effect of hPTH-(1-34)
on PG synthase can be blocked by the addition of
actinomycin D, and the translational effect can be
blocked by the addition of cycloheximide. At this
moment, the authors are not able to conclude
whether the stimulatory effect of hPTH-(1-34) on
PG synthase occurs at the early transcriptional stage
and/or the translational stage. It is possible that
both stages are affected by hPTH-(1-34). However,
it has been reported that hPTH-(1-34) stimulates
the synthesis of DNA in the central bone of
calvaria,as The biosynthesis of this enzyme in chick
calvaria may be regulated by a specific gene.
Isolation and determination of this specific gene
might be a better way to clarify the real mechanism
of hPTH-(1-34) acting on chick calvaria.
The incubation mixtures were treated with
stannous chloride (1.9 mg/ml, 10/,M) in ethanol in
order to reduce prostaglandin endoperoxide to
PGF2.
4 The results of these experiments do not
show a complete reduction of PGE2 production.
The synthesis of both PGE2 and PGF2 may
preclude the possibility of non-enzymic reduction
of prostaglandin endoperoxide to these prostaglan-
dins. The data also reveal that part of the
stimulatory effect of hPTH-(1-34) on PG synthase
is blocked by the addition of stannous chloride. The
basal levels of this enzyme activity are not changed
by SnCl2, and a certain degree of the stimulatory
effect of hPTH-(1-34) still remains (Table 1). In
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view of the partial inhibition by SnC12, it is
quite possible that part of the increased activity may
be due to induction of the PG endoperoxide E
isomerase by hPTH-(1-34) that converts PGH2
to PGE2.
PG synthase contains both cyclooxygenase and
peroxidase activities within a single protein.
Cyclooxygenase component converts arachidonic
acid to a hydroperoxy endoperoxide (PGG2). The
PGG2 then reacts with PG synthase in a
peroxidation reaction to give compound I (PGHS
I), which subsequently converts to compound II
(PGHS II). Native PG synthase is then re-
generated.
34 Hsuanyu and Dunford
35 have demon-
strated that the whole peroxidase cycle is rapidly
completed (within seconds), and a mixture of
compound I and compound 1I was achieved at a
very early stage rather than pure compound I.
Although the inducible form ofPG synthase is now
considered to be PGHS II, the authors are not able
to conclude which form of PG synthase was
activated by hPTH-(1-34) in the present study.
PG synthase has been discovered to be a
membrane-bound protein in other tissues.
16-21
However, this enzyme has never been proved to be
a membrane-bound protein in skeletal tissues. This
communication strongly supports the view that PG
synthase is a membrane-bound enzyme in chick
calvaria.
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